CDXS
Price
$2.44
Change
+$0.01 (+0.41%)
Updated
Sep 15 closing price
Capitalization
220.25M
44 days until earnings call
JANX
Price
$23.69
Change
+$0.13 (+0.55%)
Updated
Sep 16, 10:42 AM (EDT)
Capitalization
1.42B
56 days until earnings call
Interact to see
Advertisement

CDXS vs JANX

Header iconCDXS vs JANX Comparison
Open Charts CDXS vs JANXBanner chart's image
Codexis
Price$2.44
Change+$0.01 (+0.41%)
Volume$454.44K
Capitalization220.25M
Janux Therapeutics
Price$23.69
Change+$0.13 (+0.55%)
Volume$400
Capitalization1.42B
CDXS vs JANX Comparison Chart in %
Loading...
CDXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CDXS vs. JANX commentary
Sep 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDXS is a Hold and JANX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 16, 2025
Stock price -- (CDXS: $2.44 vs. JANX: $23.56)
Brand notoriety: CDXS and JANX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDXS: 44% vs. JANX: 69%
Market capitalization -- CDXS: $220.25M vs. JANX: $1.42B
CDXS [@Biotechnology] is valued at $220.25M. JANX’s [@Biotechnology] market capitalization is $1.42B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.82B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDXS’s FA Score shows that 0 FA rating(s) are green whileJANX’s FA Score has 0 green FA rating(s).

  • CDXS’s FA Score: 0 green, 5 red.
  • JANX’s FA Score: 0 green, 5 red.
According to our system of comparison, CDXS is a better buy in the long-term than JANX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDXS’s TA Score shows that 3 TA indicator(s) are bullish while JANX’s TA Score has 4 bullish TA indicator(s).

  • CDXS’s TA Score: 3 bullish, 6 bearish.
  • JANX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, JANX is a better buy in the short-term than CDXS.

Price Growth

CDXS (@Biotechnology) experienced а -0.41% price change this week, while JANX (@Biotechnology) price change was -5.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.45%. For the same industry, the average monthly price growth was +7.05%, and the average quarterly price growth was +34.61%.

Reported Earning Dates

CDXS is expected to report earnings on Oct 30, 2025.

JANX is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+3.45% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JANX($1.42B) has a higher market cap than CDXS($220M). CDXS YTD gains are higher at: -48.847 vs. JANX (-55.996). CDXS has higher annual earnings (EBITDA): -52.78M vs. JANX (-142.8M). JANX has more cash in the bank: 996M vs. CDXS (66.3M). JANX has less debt than CDXS: JANX (22.2M) vs CDXS (69M). CDXS has higher revenues than JANX: CDXS (57.2M) vs JANX (439K).
CDXSJANXCDXS / JANX
Capitalization220M1.42B16%
EBITDA-52.78M-142.8M37%
Gain YTD-48.847-55.99687%
P/E RatioN/AN/A-
Revenue57.2M439K13,030%
Total Cash66.3M996M7%
Total Debt69M22.2M311%
FUNDAMENTALS RATINGS
CDXS: Fundamental Ratings
CDXS
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CDXSJANX
RSI
ODDS (%)
Bullish Trend 1 day ago
81%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 19 days ago
85%
Bullish Trend 6 days ago
85%
Declines
ODDS (%)
Bearish Trend 14 days ago
83%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CDXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KLKBY5.29N/A
N/A
Kuala Lumpur Kepong Berhad
AELIY8.22N/A
N/A
Anadolu Hayat Emeklilik AS
CHHQY29.50N/A
N/A
China Hongqiao Group Limited
SOBS28.59-0.41
-1.41%
Solvay Bank (NY)
NRVTF0.07N/A
-6.00%
NORAM LITHIUM CORP